Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be held on 06th November 2026

Date: 30th October 2026 BSE Limited Phiroze Jeejeebhoy Towers 21st Floor, Dalal Street, Mumbai – 400001 BSE Scrip Code: 524322 Subject: Intimation of Board Meeting to be held on 06 th November 2026 Dear Sir/Madam, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on 06th November 2026 at the Registered Office of the Company situated at No.3, 2nd Floor, Swaminathan Street, West Mambalam, Chennai-600033, inter-alia, to consider and approve the following business: 1. To consider and approve the unaudited financial results for the quarter ended on 30th September 2026 pursuant to regulation 33 of SEBI (Listed Obligations and Disclosure Requirements) Regulations, 2015. 2. Any other agenda with permission of chair. We request you to take the above information on records. Yours faithfully, For Aanjaay Industries Limited (Formerly known as Kabra Drugs Limited) Nanjappan Aravind Managing Director DIN: 01895602